TABLE 1.

General overview of classification of patients with BMI ≥25 into EOSS stages based on obesity‐related comorbidities and disease burden

EOSS 0/1	EOSS 2	EOSS 3/4
Absence of obesity‐related comorbidities with or without end‐organ damage or mild disease burden HbA1c <6.5% Absence of DM Total cholesterol <200 mg/dl LDL <130 mg/dl HDL ≥40 mg/dl Triglycerides <150 mg/dl Absence of CAD Absence of HTN Absence of HF Absence of vascular disease Absence of CKD Absence of ESRD Absence of COPD or other lung diseases Varicose veins Haemorrhoids Abdominal Hernia Genital disorders Other joint disorders Back problems Sprains and strains Absence of meds administered	Presence of obesity‐related comorbidities without end‐organ damage or moderate disease burden HbA1c ≥6.5% Presence of DM or DM meds Presence of HTN or HTN meds Presence of HLD or HLD meds Total cholesterol ≥200 mg/dl LDL ≥130 mg/dl HDL < 40 mg/dl Triglycerides ≥150 mg/dl Presence of OA or OA meds Presence of Gout or Gout meds Presence of mood disorders or meds for mood disorders Presence of colon, kidney or oesophageal cancer Presence of GERD or GERD meds Presence of biliary tract disease Presence of female genital prolapse Presence of COPD or other lung diseases Presence of RA Presence of circulatory disease	Presence of obesity‐related comorbidities with end‐organ damage or severe disease burden Presence of HF or HF meds Presence of MI or antiplatelet meds Presence of vascular disease or cilostazol Presence of CAD Presence of stroke, TIA, cerebrovascular disease, precerebral artery stenosis/occlusion Presence of CKD or ESRD Presence of DM with complications Presence of HTN with complications Presence of chronic ulcer Presence of vein or lymphatic disease Presence of schizophrenia or schizophrenia meds

Abbreviations: BMI, body mass index; CAD, coronary artery disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; EOSS, Edmonton Obesity Staging System; ESRD, end stage renal disease; GERD, gastroesophageal reflux disease; HbA1C, (haemoglobin A1C); LDL, low‐density lipoprotein; HDL, high‐density lipoprotein; HF, heart failure; HLD, hyperlipidaemia; HTN, hypertension; OA, osteoarthritis; RA, rheumatoid arthritis; MI, myocardial infarction; TIA, transient ischemic attack.